When it comes to managing cholesterol, statins are one of the most commonly prescribed medications. But are they the right choice for all those with cholesterol? The answers are two-fold.
First, statins are widely used to reduce the risk of cardiovascular diseases. They include:
These drugs are particularly helpful for those with high levels of circulating LDL-C, which is a bad sign for the heart. Statins are also effective at lowering LDL-C by reducing the amount of LDL cholesterol the body can absorb, thus helping statins to help lower your LDL-C levels.
In addition, statins also have anti-estrogenic effects. They are thought to reduce the activity of estrogen receptors in certain tissues, such as the uterus, ovaries, brain, and stomach. For example, in women with liver disease, statins are thought to lower estrogen levels.
When statins are used to lower cholesterol, they also help with the liver’s metabolic processes. This process is called hepatic cholesterol metabolism.
Statins also reduce the activity of enzymes called CYP2D6 (catechol-17-dione and 3-hydroxy-3-methylglutaryl coenzyme A reductase, or CYP2D6) in the liver. This leads to lower LDL-C levels.
If statins are not effective in lowering LDL-C levels, they can be used to lower the risk of heart disease. But are they the right choice for all those with high levels of circulating LDL-C?
The answer is a resounding no.
Statins are not the only cholesterol-lowering agents that are available to all those with high levels of circulating LDL-C. Other statins are available for some heart and liver conditions, but these drugs have a very small risk of cardiovascular events. Some are available for people with diabetes, some for people with high cholesterol.
For instance, statins may be used as the first-line treatment for people with type 2 diabetes who do not respond to other lipid-lowering therapies. Other statins are available for people with type 2 diabetes who have a high level of circulating LDL-C.
The FDA approved these drugs in August 2011 for the treatment of coronary artery disease (CAD), a type of high cholesterol that can cause serious heart disease. But some statins are now available for people with high levels of circulating LDL-C, and many are now available for people with high levels of LDL-C.
The FDA has approved two new statins, or statins, to be used in patients with high levels of circulating LDL-C. These are:
For people with high levels of circulating LDL-C, statins are the best choice. But, as a rule, they can be very dangerous. It takes time for the statins to be effective in lowering LDL-C.
Statins are also a great option for people who have liver disease, or who have a history of liver disease.
If you are taking statins, it is important to talk to your doctor about the potential risks and benefits of taking them. You should also talk to your doctor about your cholesterol levels and your risk of developing a statin.
Sold and Supplied by Healthylife Pharmacy
This product is a Prescription Only Medicine (S4) and is sold by Healthylife Pharmacy, an independently owned and operated pharmacy business. This prescription product requires a valid Australian script.
Medicare CardNo MedicareConcession
$11.95
Healthylife provides general product information such as nutritional information, country of origin and product packaging for your convenience. This information is intended as a guide only, including because products change from time to time. Please read product labels before consuming. For therapeutic goods, always read the label and follow the directions for use on pack. If you require specific information to assist with your purchasing decision, we recommend that you contact the manufacturer via the contact details on the packaging or email us at [email protected]. Product ratings and reviews are taken from various sources including Bazaarvoice. Healthylife does not represent or warrant the accuracy of any statements, claims or opinions made in product ratings and reviews.
How to use:For Adults:Take 1 tablet daily for 5 days daily. Swallow the tablet whole with water; do not crush or chew it. It may be taken with or without food.
For Children:Swallow the tablet whole with water; do not use if you have previously had an allergic reaction to something else, such as foods, dyes or preservatives.
Inactive ingredients:Please read the enclosed leaflet carefully to ensure you misunderstood
Ingredients:5mg/mL Carvway Red No. 6 Finasteride 5mg/mL 1mg/mL 0.1% (oral)
Healthylife reserves the right to revise or update existing recommendations or state any forward-lookingness conclusion in the event of product recall or marketing notification.
Healthylife does not assume any responsibility for any product recall or marketing. Its role is as sole source of healthcare information. By sharing your information with the best possible provider, Healthylife ensures that you have an adequate supply of prescription medications available to you for your needs.
Active ingredient(s):Healthylife receives major payment from:A nationally recognized money-laundering syndicate
Healthylife provides general product information like price, quantity and much more. This information is intended as a guide only, but Healthylife does not represent or warrant the accuracy of any statements/beliefs made in active ingredient(s)Contributing Ingredients
Healthylife makes every effort to provide accurate and updated information about this product. However, the provided information is not intended to replace or substitute for the advice of a licensed healthcare professional. You should not take shortcuts about other uses.
Warnings and precautions:Healthylife contains the following warnings and precautions:
AstraZeneca PLC (AZN) announced today that it has received final approval from the United States Food and Drug Administration (USFDA) for the company's cholesterol-lowering drug Crestor® (rosuvastatin calcium). Crestor is a statin that is widely used to treat high cholesterol, but the FDA has not approved it for this use, according to the company. The drug's manufacturer is AstraZeneca PLC, which acquired the rights to Crestor from the German company in 2012. The drug is indicated for the treatment of type 2 diabetes. It is also indicated for the treatment of advanced mixed dyslipidaemia (ADHD) and hyperlipidaemia (HDL), both of which are very common in adults.
Crestor's approval will be seen as an important addition to AstraZeneca PLC's portfolio, but it will be important to ensure that the company's cholesterol-lowering strategy is effective and that it is being taken seriously. By sharing these results, the company will be better positioned to deliver the full benefits of Crestor. In addition, the drug will not have a high-risk or a high-benefit profile for its patients, but it is a reasonable candidate for the treatment of ADHD and/or hyperlipidaemia in patients with advanced mixed dyslipidaemia. By sharing these results, AstraZeneca will be more likely to be successful in treating ADHD and/or hyperlipidaemia in adults, who may need treatment with other statins, such as atorvastatin or rosuvastatin.
Dr. Steven Nissen, the president of AstraZeneca PLC, said, "We are excited to share the results of this trial with AstraZeneca, which has been an excellent addition to our portfolio, especially for the patients who may have a more challenging disease with the highest cardiovascular risk factors. We believe Crestor is an important addition to our pipeline of new medicines for which there are currently no approved medications available."
The FDA has approved Crestor for the treatment of type 2 diabetes in adults. It is currently in Phase 3 trials to determine whether it could be used in people with diabetes who have not responded to traditional treatment options. However, it is not yet clear what effect it will have on patients who do not respond to traditional treatments, and the results will be published in the May 2005 issue of the Journal of the American Medical Association. The results will also be shared with other diabetes management and treatment plans and may not provide the full benefits of Crestor.
The results of a Crestor clinical trial are available on.AstraZeneca PLC's Crestor is a cholesterol-lowering statin that is indicated for the treatment of high cholesterol, but the FDA has not approved it for this use, according to the company. It is also indicated for the treatment of advanced mixed dyslipidaemia (ADHD) and hyperlipidaemia, both of which are very common in adults.
The company's Crestor is a treatment for the treatment of hypercholesterolemia, which is a condition in which the body's cholesterol levels are too high. It can also be used as a second line treatment for adults with a high LDL-cholesterol, because it works by blocking the uptake of LDL-cholesterol by certain cells. Crestor is currently the only FDA-approved treatment for this condition.
Crestor is a cholesterol-lowering statin that has been in clinical use for many years. In 2004, Crestor was approved for the treatment of type 2 diabetes. In 2007, AstraZeneca PLC was approved for the treatment of ADHD. Crestor was initially approved for the treatment of this disease in people with a high LDL-cholesterol, but it was later approved for this use in patients with type 2 diabetes. It is not yet clear what effect it will have on patients who do not respond to traditional treatment options, but the results of the clinical trial will be published in the May 2005 issue of the Journal of the American Medical Association.
About the Company
The Company is a privately held, integrated biopharmaceutical company developing and delivering a range of biopharmaceutical products in a broad range of therapeutic areas.
The Company develops, manufactures, and markets a variety of biopharmaceutical products for the management of a broad range of diseases, including cardiovascular, respiratory, infectious, oncology, and neuroscience, and has a portfolio of more than 200 products. The Company has operations in more than 15 countries and is listed on the London Stock Exchange.
The recommended dosage of Crestor is 10 mg. It is taken once or twice daily, depending on the condition you are treating. The dosage may be increased or decreased based on the response to treatment. It is important to follow the doctor’s instructions. The dosage of Crestor is usually based on your condition and response to treatment.
To reduce the risk of side effects, Crestor can be used as needed for a long period of time. If you are experiencing symptoms, your doctor may recommend taking it as soon as possible. However, it can take longer to see effects if you have liver problems or are taking other medications. Regular monitoring and medical treatment is essential.
The recommended dosage is 10 mg.
It is also recommended to take Crestor at the same time each day for the same number of times per day. However, it may be taken with a meal, as needed, to avoid an upset stomach. It is important to take Crestor at the same time each day for the same amount of time.
If you are on blood thinners, you should avoid taking the Crestor. It is advised to take it at the same time each day for the same amount of time.
It is important to take it as soon as possible.
The recommended dosage for Crestor is 10 mg.
To reduce the risk of side effects, Crestor can be used as needed for a long time.
Stade de France Pharmacy